Cargando…
A Health Technology Assessment in Maxillofacial Cancer Surgery by Using the Six Sigma Methodology
Squamous cell carcinoma represents the most common cancer affecting the oral cavity. At the University of Naples “Federico II”, two different antibiotic protocols were used in patients undergoing oral mucosa cancer surgery from 2006 to 2018. From 2011, there was a shift; the combination of Cefazolin...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8469470/ https://www.ncbi.nlm.nih.gov/pubmed/34574768 http://dx.doi.org/10.3390/ijerph18189846 |
_version_ | 1784573940049379328 |
---|---|
author | Ricciardi, Carlo Orabona, Giovanni Dell’Aversana Picone, Ilaria Latessa, Imma Fiorillo, Antonella Sorrentino, Alfonso Triassi, Maria Improta, Giovanni |
author_facet | Ricciardi, Carlo Orabona, Giovanni Dell’Aversana Picone, Ilaria Latessa, Imma Fiorillo, Antonella Sorrentino, Alfonso Triassi, Maria Improta, Giovanni |
author_sort | Ricciardi, Carlo |
collection | PubMed |
description | Squamous cell carcinoma represents the most common cancer affecting the oral cavity. At the University of Naples “Federico II”, two different antibiotic protocols were used in patients undergoing oral mucosa cancer surgery from 2006 to 2018. From 2011, there was a shift; the combination of Cefazolin plus Clindamycin as a postoperative prophylactic protocol was chosen. In this paper, a health technology assessment (HTA) is performed by using the Six Sigma and DMAIC (Define, Measure, Analyse, Improve, Control) cycle in order to compare the performance of the antibiotic protocols according to the length of hospital stay (LOS). The data (13 variables) of two groups were collected and analysed; overall, 136 patients were involved. The American Society of Anaesthesiologist score, use of lymphadenectomy or tracheotomy and the presence of infections influenced LOS significantly (p-value < 0.05) in both groups. Then, the groups were compared: the overall difference between LOS of the groups was not statistically significant, but some insights were provided by comparing the LOS of the groups according to each variable. In conclusion, in light of the insights provided by this study regarding the comparison of two antibiotic protocols, the utilization of DMAIC cycle and Six Sigma tools to perform HTA studies could be considered in future research. |
format | Online Article Text |
id | pubmed-8469470 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-84694702021-09-27 A Health Technology Assessment in Maxillofacial Cancer Surgery by Using the Six Sigma Methodology Ricciardi, Carlo Orabona, Giovanni Dell’Aversana Picone, Ilaria Latessa, Imma Fiorillo, Antonella Sorrentino, Alfonso Triassi, Maria Improta, Giovanni Int J Environ Res Public Health Article Squamous cell carcinoma represents the most common cancer affecting the oral cavity. At the University of Naples “Federico II”, two different antibiotic protocols were used in patients undergoing oral mucosa cancer surgery from 2006 to 2018. From 2011, there was a shift; the combination of Cefazolin plus Clindamycin as a postoperative prophylactic protocol was chosen. In this paper, a health technology assessment (HTA) is performed by using the Six Sigma and DMAIC (Define, Measure, Analyse, Improve, Control) cycle in order to compare the performance of the antibiotic protocols according to the length of hospital stay (LOS). The data (13 variables) of two groups were collected and analysed; overall, 136 patients were involved. The American Society of Anaesthesiologist score, use of lymphadenectomy or tracheotomy and the presence of infections influenced LOS significantly (p-value < 0.05) in both groups. Then, the groups were compared: the overall difference between LOS of the groups was not statistically significant, but some insights were provided by comparing the LOS of the groups according to each variable. In conclusion, in light of the insights provided by this study regarding the comparison of two antibiotic protocols, the utilization of DMAIC cycle and Six Sigma tools to perform HTA studies could be considered in future research. MDPI 2021-09-18 /pmc/articles/PMC8469470/ /pubmed/34574768 http://dx.doi.org/10.3390/ijerph18189846 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Ricciardi, Carlo Orabona, Giovanni Dell’Aversana Picone, Ilaria Latessa, Imma Fiorillo, Antonella Sorrentino, Alfonso Triassi, Maria Improta, Giovanni A Health Technology Assessment in Maxillofacial Cancer Surgery by Using the Six Sigma Methodology |
title | A Health Technology Assessment in Maxillofacial Cancer Surgery by Using the Six Sigma Methodology |
title_full | A Health Technology Assessment in Maxillofacial Cancer Surgery by Using the Six Sigma Methodology |
title_fullStr | A Health Technology Assessment in Maxillofacial Cancer Surgery by Using the Six Sigma Methodology |
title_full_unstemmed | A Health Technology Assessment in Maxillofacial Cancer Surgery by Using the Six Sigma Methodology |
title_short | A Health Technology Assessment in Maxillofacial Cancer Surgery by Using the Six Sigma Methodology |
title_sort | health technology assessment in maxillofacial cancer surgery by using the six sigma methodology |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8469470/ https://www.ncbi.nlm.nih.gov/pubmed/34574768 http://dx.doi.org/10.3390/ijerph18189846 |
work_keys_str_mv | AT ricciardicarlo ahealthtechnologyassessmentinmaxillofacialcancersurgerybyusingthesixsigmamethodology AT orabonagiovannidellaversana ahealthtechnologyassessmentinmaxillofacialcancersurgerybyusingthesixsigmamethodology AT piconeilaria ahealthtechnologyassessmentinmaxillofacialcancersurgerybyusingthesixsigmamethodology AT latessaimma ahealthtechnologyassessmentinmaxillofacialcancersurgerybyusingthesixsigmamethodology AT fiorilloantonella ahealthtechnologyassessmentinmaxillofacialcancersurgerybyusingthesixsigmamethodology AT sorrentinoalfonso ahealthtechnologyassessmentinmaxillofacialcancersurgerybyusingthesixsigmamethodology AT triassimaria ahealthtechnologyassessmentinmaxillofacialcancersurgerybyusingthesixsigmamethodology AT improtagiovanni ahealthtechnologyassessmentinmaxillofacialcancersurgerybyusingthesixsigmamethodology AT ricciardicarlo healthtechnologyassessmentinmaxillofacialcancersurgerybyusingthesixsigmamethodology AT orabonagiovannidellaversana healthtechnologyassessmentinmaxillofacialcancersurgerybyusingthesixsigmamethodology AT piconeilaria healthtechnologyassessmentinmaxillofacialcancersurgerybyusingthesixsigmamethodology AT latessaimma healthtechnologyassessmentinmaxillofacialcancersurgerybyusingthesixsigmamethodology AT fiorilloantonella healthtechnologyassessmentinmaxillofacialcancersurgerybyusingthesixsigmamethodology AT sorrentinoalfonso healthtechnologyassessmentinmaxillofacialcancersurgerybyusingthesixsigmamethodology AT triassimaria healthtechnologyassessmentinmaxillofacialcancersurgerybyusingthesixsigmamethodology AT improtagiovanni healthtechnologyassessmentinmaxillofacialcancersurgerybyusingthesixsigmamethodology |